Off-label use of tacrolimus in children with Henoch-Schonlein purpura nephritis: Efficacy and safety
Archives of Diseases in Childhood Sep 29, 2017
Zhao Z, et al. - The purpose of this analysis was to determine the efficacy and safety of tacrolimus in children with Henoch-Schonlein purpura nephritis (HSPN). It was inferred that tacrolimus could serve as an effective, and well-tolerated drug for the treatment of HSPN, in children.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
